|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 487/04 | |
| A61K 31/4985 | |||
| A61K 31/519 | |||
| A61P 25/00 |
| (11) | Number of the document | 3288945 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16721038.4 |
| Date of filing the European patent application | 2016-04-28 | |
| (97) | Date of publication of the European application | 2018-03-07 |
| (45) | Date of publication and mention of the grant of the patent | 2019-09-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/029791 |
| Date | 2016-04-28 |
| (87) | Number | WO 2016/176457 |
| Date | 2016-11-03 |
| (30) | Number | Date | Country code |
| 201562154310 P | 2015-04-29 | US |
| (72) |
SAVALL, Bradley M., US
SWANSON, Devin M., US
WU, Dongpei, US
AMERIKS, Michael K., US
|
| (73) |
Janssen Pharmaceutica NV,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (54) | IMIDAZOPYRAZINES AND PYRAZOLOPYRIMIDINES AND THEIR USE AS AMPA RECEPTOR MODULATORS |
| IMIDAZOPYRAZINES AND PYRAZOLOPYRIMIDINES AND THEIR USE AS AMPA RECEPTOR MODULATORS |